Evaluation of probiotic usage on the intestinal microbiota diversity in patiets whith celiac disease; a clinical trial study

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20171225038063N1

Enrollment

Registered

2019-10-29

Start date

2019-05-04

Completion date

Unknown

Last updated

2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Celiac. Disease of intestine, unspecified

Interventions

Intervention 1: Intervention group: Probiotic capsule, capsule formulation containing: the Lactobacillus casei, Lactobacillus acidophilus, Lactobacillus rhamnosus, Lactobacillus bulgaricus, Bifidobact

Eligibility

Sex/Gender

All

Age

15 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patient under gluten-free diet(GFD) Confermed having celiac disease based on serology and pathology tests

Exclusion criteria

Exclusion criteria: Pregnancy People with the disease Crohn, colitis ulcerative, short bowel syndrome, mouth and stomach surgery, cancer and hepatitis Use of steroids, antibiotics, and nonsteroidal anti-inflammatory drug 4 weeks before the study Alcohol consumption

Design outcomes

Primary

Measure	Time frame
Fold change in abundance of intestinal Microbiota of patients with celiac disease. Timepoint: 3 months. Method of measurement: Real Time PCR.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Rostami Nejad

Shahid Beheshti University of Medical Sciences

m.rostamii@gmail.com+98 21 2243 2525

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026